Recent research into neuronal regeneration for epilepsy has focused on silent, or passive, synapses—
synaptic junctions that are anatomically present but electrically inactive. These synapses may serve as
potential sites for reactivation and neuronal recovery, especially following injury or disease. "NEURON
ON," a novel bioactive moringa oil formulation enriched with CBD and delivered via exogenous
exosomes, aims to reduce oxidative stress and reawaken silent synapses. In a proof-of-concept trial,
243 patients with epilepsy (ages 25–75) received personalized sublingual doses of NEURON ON. The
oxidative stress coefficient (OSC) was measured using the LONGLIFE OXY-LORD (LLOL) calculator.
Results demonstrated that 198 participants (81.48%) showed a 50% reduction in OSC, corresponding
to a 90% oxidative stress relief rate. Additionally, patients exhibited an average 12% reduction in
estimated biological age. These findings suggest that NEURON ON may promote neuronal regeneration
by forming a melanin-like lipid interface that facilitates connectivity among low-activity neurons. Given
these outcomes, EEG evaluations are recommended to validate functional neural recovery. NEURON
ON holds promise as a personalized oxidative stress-reducing therapy for epilepsy and other oxidative
pathologies affecting neuronal connectivity.
